213 related articles for article (PubMed ID: 29541389)
1. APE1/Ref-1 redox-specific inhibition decreases survivin protein levels and induces cell cycle arrest in prostate cancer cells.
McIlwain DW; Fishel ML; Boos A; Kelley MR; Jerde TJ
Oncotarget; 2018 Feb; 9(13):10962-10977. PubMed ID: 29541389
[TBL] [Abstract][Full Text] [Related]
2. Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.
Fishel ML; Xia H; McGeown J; McIlwain DW; Elbanna M; Craft AA; Kaimakliotis HZ; Sandusky GE; Zhang C; Pili R; Kelley MR; Jerde TJ
Mol Cancer Ther; 2019 Nov; 18(11):1947-1960. PubMed ID: 31413178
[TBL] [Abstract][Full Text] [Related]
3. Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth.
Fishel ML; Jiang Y; Rajeshkumar NV; Scandura G; Sinn AL; He Y; Shen C; Jones DR; Pollok KE; Ivan M; Maitra A; Kelley MR
Mol Cancer Ther; 2011 Sep; 10(9):1698-708. PubMed ID: 21700832
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of APE1/Ref-1 Redox Signaling Alleviates Intestinal Dysfunction and Damage to Myenteric Neurons in a Mouse Model of Spontaneous Chronic Colitis.
Sahakian L; Filippone RT; Stavely R; Robinson AM; Yan XS; Abalo R; Eri R; Bornstein JC; Kelley MR; Nurgali K
Inflamm Bowel Dis; 2021 Feb; 27(3):388-406. PubMed ID: 32618996
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
Laev SS; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
[TBL] [Abstract][Full Text] [Related]
6. APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival.
Cardoso AA; Jiang Y; Luo M; Reed AM; Shahda S; He Y; Maitra A; Kelley MR; Fishel ML
PLoS One; 2012; 7(10):e47462. PubMed ID: 23094050
[TBL] [Abstract][Full Text] [Related]
7. Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic.
Shah F; Logsdon D; Messmann RA; Fehrenbacher JC; Fishel ML; Kelley MR
NPJ Precis Oncol; 2017; 1():. PubMed ID: 28825044
[TBL] [Abstract][Full Text] [Related]
8. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
Fishel ML; Kelley MR
Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
[TBL] [Abstract][Full Text] [Related]
9. Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization.
Sardar Pasha SPB; Sishtla K; Sulaiman RS; Park B; Shetty T; Shah F; Fishel ML; Wikel JH; Kelley MR; Corson TW
J Pharmacol Exp Ther; 2018 Oct; 367(1):108-118. PubMed ID: 30076264
[TBL] [Abstract][Full Text] [Related]
10. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.
Kelley MR; Cheng L; Foster R; Tritt R; Jiang J; Broshears J; Koch M
Clin Cancer Res; 2001 Apr; 7(4):824-30. PubMed ID: 11309329
[TBL] [Abstract][Full Text] [Related]
11. Exposure of Barrett's and esophageal adenocarcinoma cells to bile acids activates EGFR-STAT3 signaling axis via induction of APE1.
Bhat AA; Lu H; Soutto M; Capobianco A; Rai P; Zaika A; El-Rifai W
Oncogene; 2018 Nov; 37(46):6011-6024. PubMed ID: 29991802
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the redox function of APE1/Ref-1 in myeloid leukemia cell lines results in a hypersensitive response to retinoic acid-induced differentiation and apoptosis.
Fishel ML; Colvin ES; Luo M; Kelley MR; Robertson KA
Exp Hematol; 2010 Dec; 38(12):1178-88. PubMed ID: 20826193
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo.
Jiang A; Gao H; Kelley MR; Qiao X
Vision Res; 2011 Jan; 51(1):93-100. PubMed ID: 20937296
[TBL] [Abstract][Full Text] [Related]
15. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner.
Cun Y; Dai N; Li M; Xiong C; Zhang Q; Sui J; Qian C; Wang D
Oncol Rep; 2014 Feb; 31(2):901-9. PubMed ID: 24297337
[TBL] [Abstract][Full Text] [Related]
16. New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types.
Gampala S; Moon HR; Wireman R; Peil J; Kiran S; Mitchell DK; Brewster K; Mang H; Masters A; Bach C; Smith-Kinnamen W; Doud EH; Rai R; Mosley AL; Quinney SK; Clapp DW; Hamdouchi C; Wikel J; Zhang C; Han B; Georgiadis MM; Kelley MR; Fishel ML
Pharmacol Res; 2024 Mar; 201():107092. PubMed ID: 38311014
[TBL] [Abstract][Full Text] [Related]
17. Impact of apurinic/apyrimidinic endonuclease 1/redox factor-1 on treatment response and survival in oral squamous cell carcinoma.
Hsia KT; Liu CJ; Mar K; Lin LH; Lin CS; Cheng MF; Lee HS; Chiu SY
Head Neck; 2016 Apr; 38(4):550-9. PubMed ID: 25482590
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional Up-Regulation of APE1/Ref-1 in Hepatic Tumor: Role in Hepatocytes Resistance to Oxidative Stress and Apoptosis.
Di Maso V; Mediavilla MG; Vascotto C; Lupo F; Baccarani U; Avellini C; Tell G; Tiribelli C; Crocè LS
PLoS One; 2015; 10(12):e0143289. PubMed ID: 26624999
[TBL] [Abstract][Full Text] [Related]
19. Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.
Fishel ML; Wu X; Devlin CM; Logsdon DP; Jiang Y; Luo M; He Y; Yu Z; Tong Y; Lipking KP; Maitra A; Rajeshkumar NV; Scandura G; Kelley MR; Ivan M
J Biol Chem; 2015 Jan; 290(5):3057-68. PubMed ID: 25492865
[TBL] [Abstract][Full Text] [Related]
20. The intracellular localization of APE1/Ref-1: more than a passive phenomenon?
Tell G; Damante G; Caldwell D; Kelley MR
Antioxid Redox Signal; 2005; 7(3-4):367-84. PubMed ID: 15706084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]